MarketInOut Stock Screener Log In | Sign Up
 

BioNexus Gene Lab Corp

NASDAQ • Basic Materials • Specialty Chemicals • Quote as of 05/27/2026 14:49
BioNexus Gene Lab Corp stock price and volume chart

Company Profile

IndustrySpecialty Chemicals
SectorBasic Materials
ExchangeNASDAQ
Market Capitalization4.87 mln
Float1.75 mln
Earnings Date05/15/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.33
Reliable

Relative Strength

90 / 100
Top performer

Debt / Equity

0.02
Debt-free

ROE

-38.21
Deeply negative

Dividend Yield

0.00%
No dividend

Business Description

BioNexus Gene Lab Corp. is a Malaysia-based company founded in 2017 that sells chemical raw materials to manufacturers of medical, industrial, automotive, and electronic products across Southeast Asia. Its chemicals are used to make items such as handrails, clean room panels, boat hulls, and aerospace components. The company also offers non-invasive blood-based tests designed to detect early signs of disease through biomarker analysis.

Key Fundamentals

EPS-1.49
ROE-38.21
RPS4.10
ROIC-71.13
ROA-32.29
EBITDA, mln-2.80
EV / EBITDA-0.36
EV / EBIT-0.34
Revenue, mln7.43
EV / Revenue0.14

Financial Strength

Altman Z-Score4
Piotroski F-Score 4 / 9
Beneish M-Score-3.33
Short Ratio2.92
Short % of Float0.49

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.9% 87 / 100   
1 Month 8.29% 76 / 100   
2 Months 6.82% 65 / 100   
6 Months -45.98% 11 / 100   
1 Year -16.96% 27 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us